Doxorubicin hydrochloride

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2510 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Breast neoplasms	D001943	EFO_0003869	C50	80	268	111	11	61	483
Sarcoma	D012509	—	—	55	98	34	2	15	181
Ovarian neoplasms	D010051	EFO_0003893	C56	64	80	47	1	10	178
Large b-cell lymphoma diffuse	D016403	—	C83.3	34	86	40	3	3	145
Liver neoplasms	D008113	EFO_1001513	C22.0	16	50	34	5	24	116
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	26	40	29	11	4	102
Multiple myeloma	D009101	—	C90.0	21	59	20	5	2	91
Hepatocellular carcinoma	D006528	—	C22.0	10	26	21	4	26	78
Non-hodgkin lymphoma	D008228	—	C85.9	19	37	12	5	6	71
T-cell lymphoma peripheral	D016411	—	—	11	22	7	1	—	36

Show 20 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Lymphoma	D008223	—	C85.9	26	111	52	—	16	190
Neoplasms	D009369	—	C80	76	33	7	—	5	107
Hodgkin disease	D006689	—	C81	10	55	27	—	6	89
Triple negative breast neoplasms	D064726	—	—	13	43	9	—	1	62
Fallopian tube neoplasms	D005185	—	—	29	25	17	—	1	62
Leukemia	D007938	—	C95	7	26	20	—	3	51
Neuroblastoma	D009447	EFO_0000621	—	10	21	16	—	3	50
Peritoneal neoplasms	D010534	—	—	9	13	6	—	6	31
Urinary bladder neoplasms	D001749	—	C67	4	18	8	—	1	30
Endometrial neoplasms	D016889	EFO_0004230	—	3	17	11	—	—	30

Show 82 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Stomach neoplasms	D013274	EFO_0003897	C16	5	10	—	—	5	19
Male breast neoplasms	D018567	—	—	5	9	—	—	3	13
Invasive hydatidiform mole	D002820	—	D39.2	1	11	—	—	—	12
Non-small-cell lung carcinoma	D002289	—	—	4	8	—	—	—	11
Adenocarcinoma	D000230	—	—	3	6	—	—	1	9
Myelodysplastic syndromes	D009190	—	D46	6	4	—	—	—	8
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	4	5	—	—	—	8
Urologic neoplasms	D014571	—	C64-C68	3	6	—	—	—	7
Glioblastoma	D005909	EFO_0000515	—	4	4	—	—	—	7
Reactive arthritis	D016918	EFO_0007460	M02.3	1	6	—	—	—	6

Show 101 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Appendiceal neoplasms	D001063	EFO_0003880	C18.1	2	—	—	—	2	4
Cystadenocarcinoma	D003536	—	—	3	—	—	—	—	3
Cardiomyopathies	D009202	EFO_0000318	I42	1	—	—	—	2	3
Myelodysplastic-myeloproliferative diseases	D054437	—	—	2	—	—	—	—	2
Castration-resistant prostatic neoplasms	D064129	—	—	1	—	—	—	—	1
Primary myelofibrosis	D055728	—	D47.4	1	—	—	—	—	1
Myelomonocytic leukemia chronic	D015477	—	C93.1	1	—	—	—	—	1
Anemia	D000740	HP_0001903	D64.9	1	—	—	—	—	1
Leukemia myeloid chronic atypical bcr-abl negative	D054438	—	C92.2	1	—	—	—	—	1
Thrombocytosis	D013922	HP_0001894	D75.83	1	—	—	—	—	1

Show 15 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Fatigue	D005221	HP_0012378	R53.83	—	—	—	—	2	2
Pseudomyxoma peritonei	D011553	EFO_0007456	—	—	—	—	—	2	2
Cardiovascular diseases	D002318	HP_0001626	—	—	—	—	—	2	2
Taste disorders	D013651	—	—	—	—	—	—	1	1
Dysgeusia	D004408	—	R43.2	—	—	—	—	1	1
Ageusia	D000370	EFO_1001758	—	—	—	—	—	1	1
Cognitive dysfunction	D060825	HP_0001268	G31.84	—	—	—	—	1	1
Hepatitis b	D006509	—	—	—	—	—	—	1	1
Ataxia telangiectasia	D001260	Orphanet_100	G11.3	—	—	—	—	1	1
Pleural effusion	D010996	HP_0002202	J90	—	—	—	—	1	1